BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 15449173)

  • 1. Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients.
    Kim IJ; Ku JL; Kang HC; Park JH; Yoon KA; Shin Y; Park HW; Jang SG; Lim SK; Han SY; Shin YK; Lee MR; Jeong SY; Shin HR; Lee JS; Kim WH; Park JG
    Hum Genet; 2004 Nov; 115(6):498-503. PubMed ID: 15449173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH.
    Sieber OM; Lipton L; Crabtree M; Heinimann K; Fidalgo P; Phillips RK; Bisgaard ML; Orntoft TF; Aaltonen LA; Hodgson SV; Thomas HJ; Tomlinson IP
    N Engl J Med; 2003 Feb; 348(9):791-9. PubMed ID: 12606733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYH, OGG1, MTH1, and APC alterations involved in the colorectal tumorigenesis of Korean patients with multiple adenomas.
    Kim JC; Ka IH; Lee YM; Koo KH; Kim HC; Yu CS; Jang SJ; Kim YS; Lee HI; Lee KH
    Virchows Arch; 2007 Mar; 450(3):311-9. PubMed ID: 17252231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline variation in the oxidative DNA repair genes NUDT1 and OGG1 is not associated with hereditary colorectal cancer or polyposis.
    Mur P; Jemth AS; Bevc L; Amaral N; Navarro M; Valdés-Mas R; Pons T; Aiza G; Urioste M; Valencia A; Lázaro C; Moreno V; Puente XS; Stenmark P; Warpman-Berglund U; Capellá G; Helleday T; Valle L
    Hum Mutat; 2018 Sep; 39(9):1214-1225. PubMed ID: 29900613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers.
    Halford SE; Rowan AJ; Lipton L; Sieber OM; Pack K; Thomas HJ; Hodgson SV; Bodmer WF; Tomlinson IP
    Am J Pathol; 2003 May; 162(5):1545-8. PubMed ID: 12707038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the oxidative damage repair genes NUDT1, OGG1, and MUTYH in patients from mismatch repair proficient HNPCC families (MSS-HNPCC).
    Garre P; Briceño V; Xicola RM; Doyle BJ; de la Hoya M; Sanz J; Llovet P; Pescador P; Puente J; Díaz-Rubio E; Llor X; Caldés T
    Clin Cancer Res; 2011 Apr; 17(7):1701-12. PubMed ID: 21355073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First evidence for digenic inheritance in hereditary colorectal cancer by mutations in the base excision repair genes.
    Morak M; Massdorf T; Sykora H; Kerscher M; Holinski-Feder E
    Eur J Cancer; 2011 May; 47(7):1046-55. PubMed ID: 21195604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
    Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas.
    Gismondi V; Meta M; Bonelli L; Radice P; Sala P; Bertario L; Viel A; Fornasarig M; Arrigoni A; Gentile M; Ponz de Leon M; Anselmi L; Mareni C; Bruzzi P; Varesco L
    Int J Cancer; 2004 May; 109(5):680-4. PubMed ID: 14999774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of MYH germline mutations in Swiss APC mutation-negative polyposis patients.
    Russell AM; Zhang J; Luz J; Hutter P; Chappuis PO; Berthod CR; Maillet P; Mueller H; Heinimann K
    Int J Cancer; 2006 Apr; 118(8):1937-40. PubMed ID: 16287072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of inherited defects of MYH in the development of sporadic colorectal cancer.
    Kambara T; Whitehall VL; Spring KJ; Barker MA; Arnold S; Wynter CV; Matsubara N; Tanaka N; Young JP; Leggett BA; Jass JR
    Genes Chromosomes Cancer; 2004 May; 40(1):1-9. PubMed ID: 15034862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk.
    Croitoru ME; Cleary SP; Di Nicola N; Manno M; Selander T; Aronson M; Redston M; Cotterchio M; Knight J; Gryfe R; Gallinger S
    J Natl Cancer Inst; 2004 Nov; 96(21):1631-4. PubMed ID: 15523092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
    Shin KH; Park YJ; Park JG
    Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis.
    Takayama T; Ohi M; Hayashi T; Miyanishi K; Nobuoka A; Nakajima T; Satoh T; Takimoto R; Kato J; Sakamaki S; Niitsu Y
    Gastroenterology; 2001 Sep; 121(3):599-611. PubMed ID: 11522744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer.
    Schafmayer C; Buch S; Egberts JH; Franke A; Brosch M; El Sharawy A; Conring M; Koschnick M; Schwiedernoch S; Katalinic A; Kremer B; Fölsch UR; Krawczak M; Fändrich F; Schreiber S; Tepel J; Hampe J
    Int J Cancer; 2007 Aug; 121(3):555-8. PubMed ID: 17417778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of pathogenic mechanisms in multiple colorectal adenoma patients without germline APC or MYH/MUTYH mutations.
    Thirlwell C; Howarth KM; Segditsas S; Guerra G; Thomas HJ; Phillips RK; Talbot IC; Gorman M; Novelli MR; Sieber OM; Tomlinson IP
    Br J Cancer; 2007 Jun; 96(11):1729-34. PubMed ID: 17505512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
    Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
    Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both BRAF and KRAS mutations are rare in colorectal carcinomas from patients with hereditary nonpolyposis colorectal cancer.
    Miyaki M; Iijima T; Yamaguchi T; Kadofuku T; Funata N; Mori T
    Cancer Lett; 2004 Jul; 211(1):105-9. PubMed ID: 15194222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic predisposition to colorectal cancer: new pieces in the pediatric puzzle.
    Durno CA; Gallinger S
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):5-15. PubMed ID: 16819371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.